Header Logo

Connection

Michael Megaly to Time Factors

Back to Details
This is a "connection" page, showing publications Michael Megaly has written about Time Factors.
Michael Megaly
Connection Strength
1.861
Time Factors
  1. Early vs. delayed mechanical circulatory support in patients with acute myocardial infarction and cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2024 May 28; 13(5):390-397.
    View in: PubMed
    Score: 0.168
  2. Extraplaque versus intraplaque tracking in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2022 11; 100(6):1021-1029.
    View in: PubMed
    Score: 0.150
  3. Comparative Analysis of Patient Characteristics in Chronic Total Occlusion Revascularization Studies: Trials vs Real-World Registries. JACC Cardiovasc Interv. 2022 07 25; 15(14):1441-1449.
    View in: PubMed
    Score: 0.148
  4. Outcomes of successful vs. failed contemporary chronic total occlusion percutaneous coronary intervention. Cardiovasc Interv Ther. 2022 Jul; 37(3):483-489.
    View in: PubMed
    Score: 0.141
  5. Use of Intravascular Imaging in Patients With ST-Segment Elevation Acute Myocardial Infarction. Cardiovasc Revasc Med. 2021 09; 30:59-64.
    View in: PubMed
    Score: 0.130
  6. Outcomes after pacemaker implantation in patients with new-onset left bundle-branch block after transcatheter aortic valve replacement. Am Heart J. 2019 12; 218:128-132.
    View in: PubMed
    Score: 0.123
  7. Outcomes with retrograde versus antegrade chronic total occlusion revascularization. Catheter Cardiovasc Interv. 2020 11; 96(5):1037-1043.
    View in: PubMed
    Score: 0.123
  8. Outcomes With Deferred Versus Performed Revascularization of Coronary Lesions With Gray-Zone Fractional Flow Reserve Values. Circ Cardiovasc Interv. 2019 12; 12(12):e008315.
    View in: PubMed
    Score: 0.123
  9. Outcomes with cilostazol after endovascular therapy of peripheral artery disease. Vasc Med. 2019 08; 24(4):313-323.
    View in: PubMed
    Score: 0.118
  10. Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients. Cardiovasc Revasc Med. 2020 01; 21(1):78-85.
    View in: PubMed
    Score: 0.117
  11. Impact of transcatheter edge to edge repair in functional mitral regurgitation and cardiac resynchronization-therapy nonresponders. Catheter Cardiovasc Interv. 2024 Oct; 104(4):829-836.
    View in: PubMed
    Score: 0.043
  12. Impact of Hospital Procedural Volume on?Outcomes After Endovascular Revascularization for Critical Limb?Ischemia. JACC Cardiovasc Interv. 2021 09 13; 14(17):1926-1936.
    View in: PubMed
    Score: 0.035
  13. Contemporary Revascularization Strategies and Outcomes Among Patients With Diabetes With Critical Limb Ischemia: Insights From the National Inpatient Sample. JACC Cardiovasc Interv. 2021 03 22; 14(6):664-674.
    View in: PubMed
    Score: 0.034
  14. Outcomes of Transcarotid Versus Trans-Subclavian Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Cardiovasc Revasc Med. 2021 12; 33:20-25.
    View in: PubMed
    Score: 0.033
  15. Outcomes of transcatheter versus surgical aortic valve replacement among solid organ transplant recipients. Catheter Cardiovasc Interv. 2021 03; 97(4):691-698.
    View in: PubMed
    Score: 0.033
  16. Impact of adherence to the hybrid algorithm for initial crossing strategy selection in chronic total occlusion percutaneous coronary intervention. Rev Esp Cardiol (Engl Ed). 2021 Dec; 74(12):1023-1031.
    View in: PubMed
    Score: 0.033
  17. Temporal trends and outcomes of critical limb ischemia among patients with chronic kidney disease. Vasc Med. 2021 04; 26(2):155-163.
    View in: PubMed
    Score: 0.033
  18. Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States. Catheter Cardiovasc Interv. 2021 08 01; 98(2):217-222.
    View in: PubMed
    Score: 0.032
  19. Clinical Characteristics and Outcomes?of?STEMI Patients With Cardiogenic Shock and Cardiac Arrest. JACC Cardiovasc Interv. 2020 05 25; 13(10):1211-1219.
    View in: PubMed
    Score: 0.032
  20. Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via?Saphenous Vein Graft. JACC Cardiovasc Interv. 2020 02 24; 13(4):517-526.
    View in: PubMed
    Score: 0.031
  21. Temporal Trends and Outcomes of Transcatheter Mitral Valve Repair Among Nonagenarians. JACC Cardiovasc Interv. 2020 06 08; 13(11):1385-1387.
    View in: PubMed
    Score: 0.031
  22. Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2020 11; 96(5):1029-1035.
    View in: PubMed
    Score: 0.031
  23. Temporal Trends and Outcomes of Mechanical Complications in Patients With Acute?Myocardial Infarction. JACC Cardiovasc Interv. 2019 09 23; 12(18):1825-1836.
    View in: PubMed
    Score: 0.030
  24. In-Hospital Outcomes with Transfemoral Versus Transapical Access for Transcatheter Aortic Valve Replacement in Patients with Peripheral Arterial Disease. Cardiovasc Revasc Med. 2020 05; 21(5):604-609.
    View in: PubMed
    Score: 0.030
  25. Impact of diastolic dysfunction on long-term mortality and quality of life after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020 04 01; 95(5):1034-1041.
    View in: PubMed
    Score: 0.030
  26. Low-Risk Transcatheter Versus Surgical Aortic Valve Replacement - An Updated Meta-Analysis of Randomized Controlled Trials. Cardiovasc Revasc Med. 2020 04; 21(4):441-452.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.